 | | General Information | |
| Vendor | | Merck & Co., Inc. | | Item | | Cosopt | | Size | | 5 mL, 10 mL | | Indication | | COSOPT is indicated for the reduction of elevated intraocular pressure in patients with open-angle
glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers (failed to achieve
target IOP determined after multiple measurements over time). The IOP-lowering of COSOPT b.i.d. was
slightly less than that seen with the concomitant administration of 0.5% timolol b.i.d. and 2.0%
dorzolamide t.i.d. | | Storage | | Store COSOPT at 15 - 30° C (59 - 86° F). Protect from light. | | How Supplied | | Solution | | Generic Name | | Timolol Maleate / Dorzolamide |
| | Related Content | |
| | Product Description | |
| COSOPT (dorzolamide hydrochloride-timolol maleate ophthalmic solution) is the combination of a
topical carbonic anhydrase inhibitor and a topical beta-adrenergic receptor blocking agent. | |
| Merck & Co., Inc. | | Customer Service: 908-423-1000 | | Web site: http://www.merck.com/ | | Please mention OphthalmologyWeb.com when you contact the vendor. |
| NOTE: Medcompare disclaims any information on this site. The information found on Medcompare (Drug Guide, Product Listings and otherwise) is intended for use by medical professionals. This information is not intended to replace the information, advice or instructions from a medical doctor. Pricing information is approximate, actual prices may vary. |
|
